DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
73.52
-1.80 (-2.39%)
At close: Mar 25, 2025, 4:00 PM
73.56
+0.04 (0.05%)
After-hours: Mar 25, 2025, 6:26 PM EST

DexCom Market Cap

DexCom has a market cap or net worth of $28.74 billion as of March 25, 2025. Its market cap has decreased by -44.05% in one year.

Market Cap
28.74B
Enterprise Value
28.76B
1-Year Change
-44.05%
Ranking
Category
Stock Price
$73.52

Market Cap Chart

Since April 14, 2005, DexCom's market cap has increased from $312.50M to $28.74B, an increase of 9,097.21%. That is a compound annual growth rate of 25.43%.

History

DateMarket Cap% Change
Mar 24, 202529.43B-3.11%
Dec 31, 202430.38B-36.64%
Dec 29, 202347.95B9.61%
Dec 30, 202243.74B-15.95%
Dec 31, 202152.04B46.58%
Dec 31, 202035.50B77.33%
Dec 31, 201920.02B88.10%
Dec 31, 201810.64B113.41%
Dec 29, 20174.99B-1.16%
Dec 30, 20165.05B-24.21%
Dec 31, 20156.66B57.98%
Dec 31, 20144.21B65.82%
Dec 31, 20132.54B169.96%
Dec 31, 2012941.50M49.75%
Dec 30, 2011628.70M-21.59%
Dec 31, 2010801.80M115.77%
Dec 31, 2009371.60M352.07%
Dec 31, 200882.20M-67.11%
Dec 31, 2007249.90M-9.82%
Dec 29, 2006277.10M-26.81%
Dec 30, 2005378.60M21.15%
View and export this data all the way back to 2005. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 765.04B
UnitedHealth Group 469.66B
Johnson & Johnson 388.08B
AbbVie 356.11B
Novo Nordisk 329.56B
AstraZeneca 227.33B
Merck & Co. 221.91B
Abbott Laboratories 217.87B
Market Cap Rankings